Clark A - Search Results

1

Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.

Anwari P, Debellut F, Pecenka C, Parwiz SM, Clark A, Groman D, Safi N. Anwari P, et al. Among authors: clark a. Vaccine. 2018 Dec 14;36(51):7769-7774. doi: 10.1016/j.vaccine.2017.10.058. Epub 2017 Oct 26. Vaccine. 2018. PMID: 29107346 Free PMC article.

2

Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.

Patel MM, Clark AD, Glass RI, Greenberg H, Tate J, Santosham M, Sanderson CF, Steele D, Cortese M, Parashar UD. Patel MM, et al. Vaccine. 2009 May 14;27(22):2916-22. doi: 10.1016/j.vaccine.2009.03.016. Epub 2009 Mar 25. Vaccine. 2009. PMID: 19428901

3

Cost-effectiveness of rotavirus vaccination in peru.

Clark AD, Walker DG, Mosqueira NR, Penny ME, Lanata CF, Fox-Rushby J, Sanderson CF. Clark AD, et al. J Infect Dis. 2009 Nov 1;200 Suppl 1:S114-24. doi: 10.1086/605043. J Infect Dis. 2009. PMID: 19817591

4

Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative.

Jauregui B, Sinha A, Clark AD, Bolanos BM, Resch S, Toscano CM, Matus CR, Andrus JK. Jauregui B, et al. Among authors: clark ad. Vaccine. 2011 Jan 29;29(5):1099-106. doi: 10.1016/j.vaccine.2010.11.075. Epub 2010 Dec 7. Vaccine. 2011. PMID: 21144916 Review.

5

Cost-effectiveness analysis of the 10- and 13-valent pneumococcal conjugate vaccines in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Giglio N, Gentile A, Jimenez SG, Jáuregui B, Clark AD, Diosque M, Vizzotti C. Urueña A, et al. Among authors: clark ad. Vaccine. 2011 Jul 12;29(31):4963-72. doi: 10.1016/j.vaccine.2011.04.111. Epub 2011 May 27. Vaccine. 2011. PMID: 21621575

6

Removing the age restrictions for rotavirus vaccination: a benefit-risk modeling analysis.

Patel MM, Clark AD, Sanderson CF, Tate J, Parashar UD. Patel MM, et al. PLoS Med. 2012;9(10):e1001330. doi: 10.1371/journal.pmed.1001330. Epub 2012 Oct 23. PLoS Med. 2012. PMID: 23109915 Free PMC article.

7

Cost-effectiveness of Haemophilus influenzae type b conjugate vaccine in low- and middle-income countries: regional analysis and assessment of major determinants.

Griffiths UK, Clark A, Hajjeh R. Griffiths UK, et al. Among authors: clark a. J Pediatr. 2013 Jul;163(1 Suppl):S50-S59.e9. doi: 10.1016/j.jpeds.2013.03.031. J Pediatr. 2013. PMID: 23773595 Free PMC article.

8

Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.

Clark AD, Griffiths UK, Abbas SS, Rao KD, Privor-Dumm L, Hajjeh R, Johnson H, Sanderson C, Santosham M. Clark AD, et al. J Pediatr. 2013 Jul;163(1 Suppl):S60-72. doi: 10.1016/j.jpeds.2013.03.032. J Pediatr. 2013. PMID: 23773596 Free PMC article.

9

TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination.

Clark A, Jauregui B, Griffiths U, Janusz CB, Bolaños-Sierra B, Hajjeh R, Andrus JK, Sanderson C. Clark A, et al. Vaccine. 2013 Jul 2;31 Suppl 3:C19-29. doi: 10.1016/j.vaccine.2013.05.045. Vaccine. 2013. PMID: 23777686

10

Evaluating the potential risks and benefits of infant rotavirus vaccination in England.

Clark A, Jit M, Andrews N, Atchison C, Edmunds WJ, Sanderson C. Clark A, et al. Vaccine. 2014 Jun 17;32(29):3604-10. doi: 10.1016/j.vaccine.2014.04.082. Epub 2014 May 9. Vaccine. 2014. PMID: 24814524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,249 results

Search Page

Filters